Members |
targetComponentId |
Partner in relationship with subject |
Partner in relationship |
Parturient paresis |
Muscle weakness |
Passing no clots vaginally |
Passing no clots vaginally |
Passive exercises of patient |
Musculoskeletal exercise, passive |
Passive manipulation |
Passive movement |
Passive range of ankle extension |
Passive range of ankle plantar flexion (observable entity) |
Passive range of ankle flexion |
Passive range of ankle dorsiflexion |
Passive smoking risk |
At increased risk from passive smoking |
Past pointing |
Past pointing |
Pasteurella anatipestifer |
Riemerella anatipestifer |
Pasteurella anatis |
Gallibacterium anatis (organism) |
Pasteurella avium |
Avibacterium avium (organism) |
Pasteurella gallinarum |
Avibacterium gallinarum (organism) |
Pasteurella granulomatis |
Mannheimia granulomatis (organism) |
Pasteurella haemolytica |
Mannheimia haemolytica |
Pasteurella trehalosi |
Bibersteinia trehalosi (organism) |
Pasteurella volantium |
Avibacterium volantium (organism) |
Pasturella actinobacillus species |
Family Pasteurellaceae (organism) |
Patch |
Plaque |
Patch closure of endocardial cushion defect with repair of mitral cleft |
Closure of defect of atrioventricular septum with surgical patch and repair of cleft of mitral valve (procedure) |
Patch closure of endocardial cushion defect with repair of tricuspid cleft |
Closure of defect of atrioventricular septum with surgical patch and repair of cleft of tricuspid valve (procedure) |
Patellar ligament reconstruction |
Repair - action |
Paternal grandfather of subject |
Paternal grandfather |
Paternal grandmother of subject |
Paternal grandmother (person) |
Pathological alcohol intoxication |
Psychotic behaviour caused by ethanol |
Pathological dislocation of other site, NEC |
Pathological dislocation of joint |
Pathology specimen submitted |
Pathology specimen submitted (situation) |
Patient assistance |
Assisting |
Patient declined clinical trial |
Clinical trial declined |
Patient died at home |
Died at home |
Patient died at home |
Died at home |
Patient died during operation |
Died during operation (finding) |
Patient died in care home |
Died in care home |
Patient died in general practice premises |
Died in general practice premises (finding) |
Patient died in hospice |
Died in hospice |
Patient died in hospice |
Died in hospice |
Patient died in hospice |
Died in hospice |
Patient died in hospital |
Died in hospital |
Patient died in hospital |
Died in hospital |
Patient died in nursing home |
Died in nursing home (finding) |
Patient died in nursing home |
Died in nursing home (finding) |
Patient died in street |
Died in street (finding) |
Patient died in street |
Died in street (finding) |
Patient died in usual place of residence |
Died in usual place of residence |
Patient follow-up planned and scheduled |
Patient disposition |
Patient held diabetic record declined |
Provision of patient held diabetes record declined |
Patient identification band |
Identification band |
Patient immunocompromized |
Patient immunocompromised |
Patient immunosuppressed |
Patient immunosuppressed (finding) |
Patient immunosuppressed |
Patient immunosuppressed (finding) |
Patient immunosuppressed |
Patient immunosuppressed (finding) |
Patient refuses hormone replacement therapy |
Hormone replacement therapy declined |
Patient reviewed |
Patient review (procedure) |
Patient reviewed |
Patient review (procedure) |
Patient reviewed at hospital |
Review at hospital (procedure) |
Patient reviewed at hospital |
Review at hospital (procedure) |
Patient triggered inspiratory assistance |
Pressure support ventilation (regime/therapy) |
Patient written birth plan |
Patient written birth plan (record artifact) |
Pauciarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
Pauciarticular onset juvenile chronic arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
Peaceful environment |
Peaceful environment (finding) |
Peach - dietary |
Peach (substance) |
Peanut - dietary |
Peanut (substance) |
Pear - dietary |
Pear (substance) |
Pectobacterium chrysanthemi |
Dickeya chrysanthemi (organism) |
Pectoralis major myocutaneous flap plus rib |
Pectoralis major osteomyocutaneous flap of rib |
Pediatric food panel mix radioallergosorbent test |
Food mix specific IgE antibody measurement |
Pedicle flap reconstruction - action |
Flap reconstruction - action |
Pedicle transverse rectus abdominus flap |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
Pediculus humanus humanus |
Pediculus humanus |
Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
Peeling - action |
Stripping - action |
Pegaptanib 0.3mg intravitreal injection solution 1mL prefilled syringe |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
Pegvisomant 30mg powder for injection solution vial |
Pegvisomant 20 mg powder for solution for injection vial |
Pelvic exenteration, female |
Pelvic exenteration |
Pelvic somatic dysfunction |
Somatic dysfunction |
Penetrating injury caused by glass |
Penetrating injury caused by glass fragment |
Penetrating injury due to glass |
Penetrating injury caused by glass fragment |
Penicillin G benzathine 300,000unit/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial |
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection suspension 10mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection suspension 1mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 600,000unt/mL injection suspension 1mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 20mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 2mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 4mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial |
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection |